| 2001 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T370 | ECGU000370 | 2.62 |
| 2002 | Parental longevity (both parents in top 10%) | GCST006698 | 2.62 |
| 2003 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T436 | ECGU000436 | 2.61 |
| 2004 | DTI autoptx FA str r tract | GCST90385136 | 2.61 |
| 2005 | IDP dMRI TBSS ICVF Medial lemniscus L | GCST90004336 | 2.61 |
| 2006 | Retinal thickness (functional principal component 4) | GCST90455724 | 2.61 |
| 2007 | IDP dMRI TBSS MO Body of corpus callosum | GCST90003955 | 2.60 |
| 2008 | aseg lh intensity VentralDC | GCST90003775 | 2.60 |
| 2009 | Serine levels | GCST90200415 | 2.60 |
| 2010 | CD109 levels | GCST90468597 | 2.60 |
| 2011 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T371 | ECGU000371 | 2.59 |
| 2012 | Treatment/medication code - lansoprazole | Medications | UKBB00000848 | 2.59 |
| 2013 | T1 FreeSurfer aseg Brain-Stem | GCST90384149 | 2.59 |
| 2014 | BCL2L15 levels | GCST90468431 | 2.59 |
| 2015 | DARS1/EIF4B ratio | GCST90314403 | 2.59 |
| 2016 | IDP dMRI TBSS ICVF Medial lemniscus R | GCST90004335 | 2.59 |
| 2017 | F-lentils/beans liking (derived food-liking factor) | GCST90094793 | 2.58 |
| 2018 | CXCL5/SERPINE1 ratio | GCST90314354 | 2.58 |
| 2019 | CXCL5 levels | GCST90000461 | 2.58 |
| 2020 | Left-hemisphere salience/ventral attention network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302715 | 2.58 |
| 2021 | IDP T1 SIENAX peripheral grey unnormalised volume | GCST90002427 | 2.58 |
| 2022 | ADD1 levels | GCST90468233 | 2.58 |
| 2023 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T431 | ECGA000431 | 2.57 |
| 2024 | Phosphatidylcholine (40:8) levels | GCST90024299 | 2.56 |
| 2025 | aparc-pial lh area supramarginal | GCST90003171 | 2.56 |
| 2026 | Benign neoplasm of colon (PheCode 208) | GCST90475617 | 2.56 |
| 2027 | Ankylosing spondylitis, strict definition | FING00000090 | 2.55 |
| 2028 | Glycine levels | GCST90200707 | 2.55 |
| 2029 | Cholesteryl ester (16:2) levels | GCST90025238 | 2.55 |
| 2030 | End-diastolic bi-ventricular shape (principal component 9) | GCST90448488 | 2.55 |
| 2031 | Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82) | GCST90668526 | 2.55 |
| 2032 | Disorders of eyelid, lacrimal system and orbit | FING00000439 | 2.54 |
| 2033 | IDP dMRI ProbtrackX ICVF ar l | GCST90004375 | 2.54 |
| 2034 | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus L | GCST90004214 | 2.54 |
| 2035 | Lifespan | GCST90551884 | 2.53 |
| 2036 | Skin and soft tissue infections | GCST90013411 | 2.53 |
| 2037 | Cardiac defibrillator in situ (PheCode 426.92) | GCST90475961 | 2.53 |
| 2038 | Sensorineural hearing loss | FING00001291 | 2.53 |
| 2039 | Chronic bronchitis | respiratory | UKBB00000136 | 2.53 |
| 2040 | F2R levels | GCST90012010 | 2.53 |
| 2041 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T426 | ECGA000426 | 2.53 |
| 2042 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T225 | ECGA000225 | 2.52 |
| 2043 | IDP dMRI TBSS L1 Retrolenticular part of internal capsule L | GCST90004096 | 2.52 |
| 2044 | Triglycerides to total lipids ratio in large HDL | GCST90092855 | 2.52 |
| 2045 | IDP dMRI ProbtrackX FA slf r | GCST90003947 | 2.52 |
| 2046 | Duodenal ulcer | FING00000481 | 2.51 |
| 2047 | AKR1B1 levels | GCST90468273 | 2.51 |
| 2048 | Sphingomyelins levels | GCST90499972 | 2.50 |
| 2049 | CA1 levels | GCST90468510 | 2.50 |
| 2050 | Juvenile arthritis (FINNGEN) | FING00000704 | 2.50 |
| 2051 | REST UKBBICA NODEamps25 0009 | GCST90385492 | 2.50 |
| 2052 | Malignant neoplasm of breast | Malignant neoplasm of breast | UKBB00000424 | 2.50 |
| 2053 | IDP T1 SIENAX peripheral grey normalised volume | GCST90002426 | 2.49 |
| 2054 | Hearing difficulty/problems: No (UKB data field 2247_0) | GCST90042881 | 2.48 |
| 2055 | IDP T1 FAST ROIs L front operc cortex | GCST90002531 | 2.48 |
| 2056 | Illnesses of siblings - Diabetes | Family history | UKBB00000350 | 2.48 |
| 2057 | aparc-pial lh area lateralorbitofrontal | GCST90003152 | 2.47 |
| 2058 | T1 FreeSurfer a2009s rh S temporal sup area | GCST90384962 | 2.47 |
| 2059 | Weight, inverse-rank normalized | FING00001447 | 2.47 |
| 2060 | Volume of left central nucleus | GCST90474961 | 2.47 |
| 2061 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T39 | ECGU000039 | 2.47 |
| 2062 | Pulmonary embolism | GCST90468148 | 2.47 |
| 2063 | Biological Mother: Coronary Artery / Coronary Heart Disease | GCST90475488 | 2.46 |
| 2064 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T462 | ECGA000462 | 2.46 |
| 2065 | Spinal stenosis (PheCode 720) | GCST90476233 | 2.46 |
| 2066 | Recent worrying too much about different things | Anxiety | UKBB00000746 | 2.45 |
| 2067 | Diaphragmatic hernia | FING00000419 | 2.45 |
| 2068 | IDP dMRI TBSS FA Cingulum cingulate gyrus R | GCST90003911 | 2.45 |
| 2069 | Principal component-derived dietary pattern 44 | GCST90133049 | 2.45 |
| 2070 | IDP dMRI ProbtrackX ICVF ml r | GCST90004393 | 2.45 |
| 2071 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92) | GCST90320655 | 2.45 |
| 2072 | Right-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302805 | 2.45 |
| 2073 | Cholesteryl esters to total lipids ratio in large HDL | GCST90092847 | 2.44 |
| 2074 | EIF1AX levels | GCST90241120 | 2.44 |
| 2075 | Phospholipids to Total Lipids in IDL percentage | GCST90497644 | 2.44 |
| 2076 | PSRC1/SMAD1 ratio | GCST90315741 | 2.44 |
| 2077 | Trans-2-hexenoylglycine metabolite level | GCST90616136 | 2.44 |
| 2078 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T428 | ECGA000428 | 2.44 |
| 2079 | aseg global volume BrainSegNotVentSurf | GCST90002592 | 2.44 |
| 2080 | aseg rh volume Pallidum | GCST90002640 | 2.44 |
| 2081 | Concentration of large HDL particles | GCST90092851 | 2.43 |
| 2082 | CALCOCO1/TBC1D5 ratio | GCST90313610 | 2.43 |
| 2083 | Other disorders of ear | FING00001023 | 2.42 |
| 2084 | QC T1-to-standard linear alignment discrepancy | GCST90006345 | 2.42 |
| 2085 | COL15A1 levels | GCST90468811 | 2.41 |
| 2086 | T1 CAT volume R CrusI | GCST90384120 | 2.41 |
| 2087 | IDP dMRI TBSS FA Posterior thalamic radiation R | GCST90003905 | 2.41 |
| 2088 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T323 | ECGU000323 | 2.40 |
| 2089 | FETUB levels | GCST90469215 | 2.40 |
| 2090 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T330 | ECGU000330 | 2.40 |
| 2091 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T31 | ECGU000031 | 2.40 |
| 2092 | Personal history of certain other diseases | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000642 | 2.40 |
| 2093 | GBP2 levels | GCST90469312 | 2.40 |
| 2094 | BLVRB/CA3 ratio | GCST90313523 | 2.39 |
| 2095 | Other headache syndromes | FING00001055 | 2.39 |
| 2096 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T194 | ECGU000194 | 2.39 |
| 2097 | Malignant neoplasm of liver, primary (PheCode 155.1) | GCST90475569 | 2.39 |
| 2098 | ATXN10/SLC27A4 ratio | GCST90313399 | 2.39 |
| 2099 | GRAP2/PPP1R2 ratio | GCST90314985 | 2.38 |
| 2100 | Ischemic heart disease (PheCode 411) | GCST90475929 | 2.38 |
| 2101 | Free Cholesterol to Total Lipids in IDL percentage | GCST90497576 | 2.38 |
| 2102 | SERPINA11 levels | GCST90470580 | 2.38 |
| 2103 | Sleep duration | GCST003839 | 2.37 |
| 2104 | FYN levels | GCST90243200 | 2.37 |
| 2105 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T279 | ECGU000279 | 2.37 |
| 2106 | KDR levels | GCST90243323 | 2.37 |
| 2107 | Cholesterol to total lipids in large LDL percentage (UKB data field 23615) | GCST90269712 | 2.36 |
| 2108 | Concentration of IDL particles | GCST90497614 | 2.36 |
| 2109 | IDP dMRI TBSS MD Anterior limb of internal capsule L | GCST90004044 | 2.36 |
| 2110 | IDP dMRI TBSS MD Inferior cerebellar peduncle L | GCST90004038 | 2.36 |
| 2111 | Phospholipid levels in IDL | GCST90092839 | 2.36 |
| 2112 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44) | GCST90320863 | 2.36 |
| 2113 | Mean arterial pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000438 | 2.36 |
| 2114 | CD40LG/SERPINE1 ratio | GCST90313826 | 2.36 |
| 2115 | Breast conditions, congenital or relating to hormones (PheCode 612) | GCST90476162 | 2.35 |
| 2116 | Cholesteryl Esters to Total Lipids in IDL percentage | GCST90497539 | 2.34 |
| 2117 | F-sweetened coffee drink liking (derived food-liking factor) | GCST90094853 | 2.34 |
| 2118 | APOBR levels | GCST90468334 | 2.34 |
| 2119 | Cholesteryl Esters to Total Lipids in Medium VLDL percentage | GCST90498944 | 2.34 |
| 2120 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T427 | ECGA000427 | 2.34 |
| 2121 | IDP dMRI TBSS MD Posterior thalamic radiation R | GCST90004055 | 2.33 |
| 2122 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T224 | ECGU000224 | 2.33 |
| 2123 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T196 | ECGU000196 | 2.33 |
| 2124 | Androstenediol (3beta,17beta) monosulfate (2) levels | GCST90199871 | 2.33 |
| 2125 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T283 | ECGU000283 | 2.33 |
| 2126 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T226 | ECGA000226 | 2.32 |
| 2127 | Left-hemisphere control network to left-hemisphere default mode network white-matter structural connectivity | GCST90302744 | 2.32 |
| 2128 | Lysophosphatidylcholine (20:3) [sn1] levels | GCST90024169 | 2.32 |
| 2129 | IDP dMRI ProbtrackX ISOVF ifo r | GCST90004538 | 2.32 |
| 2130 | T1 FreeSurfer DK rh MeanThickness thickness | GCST90385757 | 2.31 |
| 2131 | aparc-a2009s rh volume S-intrapariet+P-trans | GCST90003054 | 2.31 |
| 2132 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T56 | ECGU000056 | 2.31 |
| 2133 | Free Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500798 | 2.31 |
| 2134 | Plasma N-acetylhistidine levels in chronic kidney disease | GCST90265576 | 2.31 |
| 2135 | Milky sweets liking | GCST90094802 | 2.31 |
| 2136 | Menorrhagia | FING00000808 | 2.30 |
| 2137 | Fasting blood insulin | GCST005185 | 2.30 |
| 2138 | Ulcer of lower limb, not elsewhere classified | FING00001385 | 2.30 |
| 2139 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T448 | ECGA000448 | 2.29 |
| 2140 | IDP T1 SIENAX brain-normalised volume | GCST90002434 | 2.29 |
| 2141 | 4-androsten-3beta,17beta-diol disulfate 1 levels | GCST90243879 | 2.29 |
| 2142 | Left eye overall retinal pigment epithelium thickness | GCST90672032 | 2.29 |
| 2143 | C1QTNF1 levels | GCST90468488 | 2.29 |
| 2144 | DKK1/ZBTB16 ratio | GCST90314486 | 2.28 |
| 2145 | Angina pectoris | circulatory system | UKBB00000030 | 2.28 |
| 2146 | Atrial fibrillation | GCST90624412 | 2.28 |
| 2147 | Spinal stenosis | musculoskeletal | UKBB00000792 | 2.28 |
| 2148 | Total lipid levels in large HDL | GCST90092850 | 2.27 |
| 2149 | wg lh intensity-contrast paracentral | GCST90003808 | 2.27 |
| 2150 | Volume of right lateral nucleus | GCST90474922 | 2.27 |
| 2151 | SSC-A on plasmacytoid Dendritic Cell | GCST90002072 | 2.27 |
| 2152 | aparc-Desikan rh area superiorparietal | GCST90003135 | 2.27 |
| 2153 | Spells in hospital | Summary Administration | UKBB00000789 | 2.27 |
| 2154 | MST1 levels | GCST90469952 | 2.27 |
| 2155 | IDP T1 FAST ROIs L cerebellum VIIb | GCST90002575 | 2.27 |
| 2156 | Osteomyelitis | FING00000911 | 2.26 |
| 2157 | Left-hemisphere default mode network to left-hemisphere default mode network white-matter structural connectivity | GCST90302759 | 2.26 |
| 2158 | CDH17/GALNT3 ratio | GCST90313940 | 2.26 |
| 2159 | Mean arterial pressure, automated reading | Cardiovascular measurement | UKBB00000434 | 2.26 |
| 2160 | Hearing difficulty/problems: Yes (UKB data field 2247_1) | GCST90042882 | 2.26 |
| 2161 | RNASE6 levels | GCST90470479 | 2.26 |
| 2162 | Arthropathy NOS | musculoskeletal | UKBB00000051 | 2.25 |
| 2163 | EIF4B/MAP4K5 ratio | GCST90314623 | 2.25 |
| 2164 | Systolic blood pressure, automated reading | Blood pressure | UKBB00000803 | 2.25 |
| 2165 | BA-exvivo lh volume BA1 | GCST90002835 | 2.24 |
| 2166 | CLIP2/DNAJA2 ratio | GCST90314127 | 2.24 |
| 2167 | Free cholesterol in large HDL | GCST90497780 | 2.24 |
| 2168 | Raynaud's syndrome | GCST90448187 | 2.24 |
| 2169 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T419 | ECGU000419 | 2.24 |
| 2170 | Back pain | symptoms | UKBB00000084 | 2.24 |
| 2171 | Hypertension (PheCode 401) | GCST90475919 | 2.24 |
| 2172 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T73 | ECGA000073 | 2.24 |
| 2173 | Free cholesterol in IDL (UKB data field 23528) | GCST90269625 | 2.24 |
| 2174 | Visceral adipose tissue normalized | GCST90267358 | 2.23 |
| 2175 | IDP T1 FIRST right putamen volume | GCST90002441 | 2.23 |
| 2176 | Abdominal fat ratio | GCST90267360 | 2.23 |
| 2177 | IDP dMRI TBSS L2 Cingulum cingulate gyrus L | GCST90004158 | 2.23 |
| 2178 | FXN/METAP1D ratio | GCST90314897 | 2.23 |
| 2179 | CA1/HMBS ratio | GCST90313573 | 2.22 |
| 2180 | Hypotaurine levels | GCST90200379 | 2.22 |
| 2181 | Operation code - bilateral oophorectomy | Operations | UKBB00000550 | 2.22 |
| 2182 | aparc-a2009s rh volume G-occipital-sup | GCST90003018 | 2.22 |
| 2183 | Phospholipid levels in large HDL | GCST90092852 | 2.22 |
| 2184 | T1 FreeSurfer a2009s lh S central thickness | GCST90384786 | 2.22 |
| 2185 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T447 | ECGA000447 | 2.22 |
| 2186 | DTI TBSS L2 Splenium of corpus callosum | GCST90384480 | 2.22 |
| 2187 | Brain age gap | GCST90558034 | 2.22 |
| 2188 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T54 | ECGU000054 | 2.21 |
| 2189 | Mean arterial pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000437 | 2.21 |
| 2190 | DTI TBSS L2 Superior fronto-occipital fasciculus L | GCST90384519 | 2.21 |
| 2191 | Rotator cuff syndrome | FING00001270 | 2.21 |
| 2192 | IDP dMRI ProbtrackX L3 slf r | GCST90004322 | 2.21 |
| 2193 | DECR1/FXN ratio | GCST90314446 | 2.20 |
| 2194 | DTI TBSS L3 Posterior limb of internal capsule R | GCST90384542 | 2.20 |
| 2195 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T368 | ECGU000368 | 2.20 |
| 2196 | aparc-a2009s rh thickness G-oc-temp-med-Lingual | GCST90003698 | 2.20 |
| 2197 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T329 | ECGU000329 | 2.20 |
| 2198 | CCL16 levels | GCST90179243 | 2.19 |
| 2199 | APOC1 levels | GCST90468336 | 2.19 |
| 2200 | Epiandrosterone sulfate levels | GCST90199752 | 2.19 |
| 2201 | PSMG3 levels | GCST90470362 | 2.19 |
| 2202 | Left-hemisphere visual network to caudate white-matter structural connectivity | GCST90302663 | 2.18 |
| 2203 | Chronic ulcer of skin, not elsewhere classified | FING00000300 | 2.18 |
| 2204 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T30 | ECGU000030 | 2.18 |
| 2205 | Spondylosis without myelopathy (PheCode 721.1) | GCST90476236 | 2.17 |
| 2206 | Retinal thickness (functional principal component 5) | GCST90455725 | 2.17 |
| 2207 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T51 | ECGU000051 | 2.17 |
| 2208 | Inpatient record format - UK HES In Patient (2015 format) | Summary Administration | UKBB00000364 | 2.17 |
| 2209 | BA-exvivo rh area BA4p | GCST90003226 | 2.17 |
| 2210 | Hippocampal right HATA volume | GCST90267969 | 2.17 |
| 2211 | Lesion of plantar nerve | FING00000720 | 2.17 |
| 2212 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T40 | ECGU000040 | 2.17 |
| 2213 | Operative procedures - Direct current cardioversion | Summary Operations | UKBB00000576 | 2.16 |
| 2214 | Total lipids in IDL | GCST90497601 | 2.16 |
| 2215 | Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24) | GCST90309358 | 2.16 |
| 2216 | PDCD6IP levels | GCST90618969 | 2.15 |
| 2217 | Principal component-derived dietary pattern 46 | GCST90133051 | 2.15 |
| 2218 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T62 | ECGU000062 | 2.15 |
| 2219 | IDP dMRI TBSS L3 Anterior limb of internal capsule L | GCST90004188 | 2.15 |
| 2220 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T32 | ECGU000032 | 2.15 |
| 2221 | NH4_C22:4 Cholesteryl ester levels in chronic kidney disease | GCST90257227 | 2.15 |
| 2222 | IDP dMRI TBSS L1 Cerebral peduncle R | GCST90004089 | 2.14 |
| 2223 | Barrett's esophagus | GCST90000515 | 2.14 |
| 2224 | Goat cheese liking | GCST90094773 | 2.14 |
| 2225 | NCF2 levels | GCST90470006 | 2.13 |
| 2226 | Sleep apnea | GCST90475257 | 2.13 |
| 2227 | CSNK1G2 levels | GCST90240608 | 2.13 |
| 2228 | Non-ischemic cardiomyopathy | FING00000873 | 2.13 |
| 2229 | IL6ST/LEPR ratio | GCST90315165 | 2.13 |
| 2230 | Bundle branch block (PheCode 426.3) | GCST90475956 | 2.13 |
| 2231 | Sphingomyelin (d18:0/16:0) levels | GCST90025741 | 2.13 |
| 2232 | Takes medication for Macular Degeneration? | GCST90475387 | 2.13 |
| 2233 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T367 | ECGU000367 | 2.13 |
| 2234 | DTI autoptx L2 str l tract | GCST90385189 | 2.13 |
| 2235 | CRNN levels | GCST90277890 | 2.12 |
| 2236 | IDP dMRI TBSS OD Posterior limb of internal capsule L | GCST90004421 | 2.12 |
| 2237 | RGMB levels | GCST90242647 | 2.12 |
| 2238 | Essential hypertension | circulatory system | UKBB00000209 | 2.12 |
| 2239 | BTN3A2 levels | GCST90468481 | 2.11 |
| 2240 | aparc-DKTatlas rh area superiorparietal | GCST90003292 | 2.11 |
| 2241 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T328 | ECGU000328 | 2.11 |
| 2242 | Cardiomyopathy | GCST90399705 | 2.11 |
| 2243 | POLR2F levels | GCST90470283 | 2.10 |
| 2244 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 111) | GCST90320674 | 2.10 |
| 2245 | IL2RA levels | GCST90469585 | 2.10 |
| 2246 | Spread type: Butter and margarine spreads vs oil-based spreads (UKB data field 1428) | GCST90132951 | 2.10 |
| 2247 | IDP dMRI TBSS FA Posterior limb of internal capsule R | GCST90003895 | 2.10 |
| 2248 | Cholesterol in IDL (UKB data field 23526) | GCST90269623 | 2.10 |
| 2249 | IL1B levels | GCST90469570 | 2.09 |
| 2250 | GDI2 levels | GCST90088004 | 2.09 |
| 2251 | ThalamNuclei rh volume CM | GCST90002742 | 2.09 |
| 2252 | Nonalcoholic fatty liver disease in overweight individuals (25<=BMI<=30) | GCST90275047 | 2.09 |
| 2253 | SH3BP1 levels | GCST90470619 | 2.09 |
| 2254 | DTI TBSS FA Superior longitudinal fasciculus L | GCST90384421 | 2.09 |
| 2255 | MNDA levels | GCST90469927 | 2.09 |
| 2256 | MYCT1 levels | GCST90618046 | 2.08 |
| 2257 | Lymphoid leukaemia (controls excluding all cancers) | FING00000741 | 2.08 |
| 2258 | Sarcoidosis | GCST90018698 | 2.08 |
| 2259 | aparc-a2009s rh area G+S-subcentral | GCST90003374 | 2.08 |
| 2260 | T1 FreeSurfer BA lh BA4p exvivo thickness | GCST90385524 | 2.08 |
| 2261 | BA-exvivo lh thickness BA3b | GCST90003516 | 2.08 |
| 2262 | aseg rh volume Putamen | GCST90002639 | 2.08 |
| 2263 | Symptoms involving digestive system (PheCode 561) | GCST90476069 | 2.08 |
| 2264 | Female infertility, associated with anovulation | FING00000537 | 2.08 |
| 2265 | DTI TBSS L1 Anterior corona radiata L | GCST90384451 | 2.08 |
| 2266 | Phosphatidylcholine (14:0_22:6) levels | GCST90024234 | 2.08 |
| 2267 | Diseases of sebaceous glands (PheCode 706) | GCST90476210 | 2.08 |
| 2268 | Free cholesterol to total lipids ratio in small HDL | GCST90092949 | 2.07 |
| 2269 | Prevotellamassilia abundance in stool | GCST90032517 | 2.07 |
| 2270 | SFRP2 levels | GCST90242727 | 2.07 |
| 2271 | Usual side of head for mobile phone use - Right | Electronic device use | UKBB00000890 | 2.07 |
| 2272 | Anxiety, nerves or generalized anxiety disorder | Mental distress | UKBB00000039 | 2.07 |
| 2273 | Principal component-derived dietary pattern 42 | GCST90133047 | 2.07 |
| 2274 | Cholesterol to total lipids ratio in large HDL | GCST90092845 | 2.06 |
| 2275 | Milk type used: Soy milk vs never have milk (UKB data field 1418) | GCST90132943 | 2.06 |
| 2276 | IDP dMRI ProbtrackX MD fmi | GCST90004230 | 2.06 |
| 2277 | Type 2 diabetes with neurological manifestations (PheCode 250.24) | GCST90475676 | 2.06 |
| 2278 | Mean arterial pressure, automated reading | Cardiovascular measurement | UKBB00000433 | 2.05 |
| 2279 | Other disorders of the musculoskeletal system and connective tissue | FING00001038 | 2.05 |
| 2280 | IDP T1 FAST ROIs R mid front gyrus | GCST90002458 | 2.05 |
| 2281 | Other eye problems | Eyesight | UKBB00000610 | 2.05 |
| 2282 | Pancreas volume | GCST90016669 | 2.05 |
| 2283 | CCL3 levels | GCST90012055 | 2.04 |
| 2284 | Lactose intolerance, other/unspecified | FING00000712 | 2.04 |
| 2285 | IDP dMRI TBSS L3 Superior corona radiata R | GCST90004195 | 2.04 |
| 2286 | ARHGEF10 levels | GCST90468357 | 2.03 |
| 2287 | aparc-pial rh area superiorparietal | GCST90003202 | 2.03 |
| 2288 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 94) | GCST90320913 | 2.02 |
| 2289 | sodium (minimum, inv-norm transformed) | GCST90476397 | 2.02 |
| 2290 | Other enthesopathies | FING00001045 | 2.02 |
| 2291 | Divergent concomitant strabismus | FING00000470 | 2.02 |
| 2292 | C-reactive protein | Blood biochemistry | UKBB00000113 | 2.02 |
| 2293 | aparc-Desikan rh volume postcentral | GCST90002822 | 2.02 |
| 2294 | Secondary diabetes mellitus (PheCode 249) | GCST90475655 | 2.02 |
| 2295 | Treatment/medication code - atenolol | Medications | UKBB00000842 | 2.01 |
| 2296 | IDP dMRI TBSS ICVF Posterior corona radiata R | GCST90004353 | 2.01 |
| 2297 | IGFBP7 levels | GCST90469532 | 2.00 |
| 2298 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T228 | ECGU000228 | 2.00 |
| 2299 | Systolic blood pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000807 | 2.00 |
| 2300 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T377 | ECGU000377 | 2.00 |
| 2301 | aparc-Desikan rh area fusiform | GCST90003113 | 1.99 |
| 2302 | Milk type used - Full cream | Diet | UKBB00000468 | 1.99 |
| 2303 | Comfortable retirement (confirmatory factor analysis Factor 29) | GCST90309363 | 1.99 |
| 2304 | BA-exvivo rh thickness BA4a | GCST90003531 | 1.99 |
| 2305 | Systolic blood pressure | GCST90301695 | 1.99 |
| 2306 | Total cholesterol levels in small LDL | GCST90132690 | 1.98 |
| 2307 | Treatment/medication code - co-codamol | Medications | UKBB00000845 | 1.98 |
| 2308 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T198 | ECGU000198 | 1.98 |
| 2309 | STK24/TDRKH ratio | GCST90315893 | 1.98 |
| 2310 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T123 | ECGU000123 | 1.98 |
| 2311 | IDP dMRI ProbtrackX L3 ifo l | GCST90004312 | 1.97 |
| 2312 | Left-hemisphere dorsal attention network to left-hemisphere default mode network white-matter structural connectivity | GCST90302693 | 1.97 |
| 2313 | DTI autoptx L3 fmi tract | GCST90385204 | 1.97 |
| 2314 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T327 | ECGU000327 | 1.97 |
| 2315 | EHMT2 levels | GCST90241442 | 1.96 |
| 2316 | Cancer of liver and intrahepatic bile duct (PheCode 155) | GCST90475568 | 1.96 |
| 2317 | Early-onset myasthenia gravis | GCST90093465 | 1.95 |
| 2318 | PLXNA4/VASH1 ratio | GCST90315691 | 1.95 |
| 2319 | Liver fat | GCST90029073 | 1.95 |
| 2320 | DTI TBSS L2 Posterior corona radiata L | GCST90384503 | 1.94 |
| 2321 | T1 FreeSurfer aseg Left-Putamen | GCST90384145 | 1.93 |
| 2322 | ALPI levels | GCST90468285 | 1.93 |
| 2323 | DTI TBSS L2 Anterior limb of internal capsule L | GCST90384493 | 1.93 |
| 2324 | Leg predicted mass (left) | Impedance measures | UKBB00000396 | 1.93 |
| 2325 | FABP2 levels | GCST90469174 | 1.93 |
| 2326 | ERMAP levels | GCST90469147 | 1.92 |
| 2327 | Cholesteryl esters in IDL (UKB data field 23527) | GCST90269624 | 1.92 |
| 2328 | SPARC/ZBTB16 ratio | GCST90315875 | 1.92 |
| 2329 | Ulcerative ileocolitis | FING00001392 | 1.91 |
| 2330 | Hypertension | circulatory system | UKBB00000334 | 1.91 |
| 2331 | Right-hemisphere dorsal attention network to pallidum white-matter structural connectivity | GCST90302809 | 1.91 |
| 2332 | Frontal QRS-T angle | GCST90246321 | 1.91 |
| 2333 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 67) | GCST90320886 | 1.91 |
| 2334 | Smoking status (weighted GWA) | GCST90267303 | 1.91 |
| 2335 | CHMP1A levels | GCST90468746 | 1.90 |
| 2336 | aseg lh volume Accumbens-area | GCST90002626 | 1.90 |
| 2337 | C3 levels | GCST90468498 | 1.90 |
| 2338 | IDP T1 FAST ROIs L cerebellum VI | GCST90002566 | 1.90 |
| 2339 | EXTL1 levels | GCST90469161 | 1.90 |
| 2340 | Type 2 diabetes with renal manifestations (PheCode 250.22) | GCST90475670 | 1.89 |
| 2341 | Cerotoylcarnitine (C26) levels | GCST90200136 | 1.89 |
| 2342 | ICAM5 levels | GCST90241541 | 1.89 |
| 2343 | IDP dMRI TBSS ISOVF Superior longitudinal fasciculus R | GCST90004517 | 1.89 |
| 2344 | Margaroylcarnitine (C17) levels | GCST90199929 | 1.89 |
| 2345 | mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed) | GCST90475448 | 1.89 |
| 2346 | Urine X-23518 levels in chronic kidney disease | GCST90266595 | 1.88 |
| 2347 | IDP dMRI ProbtrackX MD str r | GCST90004243 | 1.88 |
| 2348 | VEGFC/ZBTB16 ratio | GCST90315946 | 1.88 |
| 2349 | IDP dMRI TBSS OD Anterior limb of internal capsule L | GCST90004419 | 1.88 |
| 2350 | Obstructive chronic bronchitis | respiratory | UKBB00000546 | 1.88 |
| 2351 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T364 | ECGU000364 | 1.87 |
| 2352 | SNRPB2 levels | GCST90470697 | 1.87 |
| 2353 | Intended management of patient (recoded) - One or more nights hospital stay | Summary Administration | UKBB00000367 | 1.87 |
| 2354 | Posterior thigh muscle volume | GCST90267353 | 1.87 |
| 2355 | Blood cell traits latent factor 12 (red cell) | GCST90559254 | 1.86 |
| 2356 | Ever sought or received professional help for mental distress | Mental distress | UKBB00000222 | 1.86 |
| 2357 | Ischemic heart disease (PheCode 411) | GCST008370 | 1.86 |
| 2358 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T363 | ECGU000363 | 1.86 |
| 2359 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T191 | ECGU000191 | 1.85 |
| 2360 | Principal component-derived dietary pattern 39 | GCST90133044 | 1.85 |
| 2361 | Free Cholesterol to Total Lipids in Small LDL percentage | GCST90499637 | 1.85 |
| 2362 | PON1 levels | GCST90470285 | 1.85 |
| 2363 | CA2/TGM2 ratio | GCST90313582 | 1.85 |
| 2364 | IDP dMRI TBSS MD Superior fronto-occipital fasciculus L | GCST90004070 | 1.85 |
| 2365 | SMOC2 levels | GCST90422773 | 1.85 |
| 2366 | MAP4K5/TBCB ratio | GCST90315384 | 1.84 |
| 2367 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T195 | ECGU000195 | 1.84 |
| 2368 | CEACAM8/PGLYRP1 ratio | GCST90314003 | 1.84 |
| 2369 | FKBP1B levels | GCST90469242 | 1.84 |
| 2370 | PPP1R2/USP8 ratio | GCST90315723 | 1.83 |
| 2371 | ThalamNuclei lh volume Pf | GCST90002722 | 1.83 |
| 2372 | Impedance of leg (left) | Impedance measures | UKBB00000358 | 1.83 |
| 2373 | wg rh intensity-contrast postcentral | GCST90003848 | 1.83 |
| 2374 | CELSR2 levels | GCST90468703 | 1.83 |
| 2375 | Omega-3 fatty acids to total fatty acids percentage | GCST90502082 | 1.83 |
| 2376 | Leg fat-free mass (left) | Impedance measures | UKBB00000393 | 1.83 |
| 2377 | DTI autoptx L2 atr r tract | GCST90385169 | 1.82 |
| 2378 | Extrapyramidal disease and abnormal movement disorders (PheCode 333) | GCST90475831 | 1.82 |
| 2379 | GP5 levels | GCST90469383 | 1.82 |
| 2380 | IDP dMRI ProbtrackX MD cgc r | GCST90004224 | 1.82 |
| 2381 | Total esterified cholesterol levels | GCST90500034 | 1.82 |
| 2382 | DTI autoptx L2 str r tract | GCST90385190 | 1.82 |
| 2383 | EBAG9/TBCC ratio | GCST90314568 | 1.82 |
| 2384 | Right-hemisphere control network to hippocampus white-matter structural connectivity | GCST90302840 | 1.82 |
| 2385 | Angina pectoris (PheCode 411.3) | GCST90475933 | 1.82 |
| 2386 | Tyrosine levels | GCST90200427 | 1.82 |
| 2387 | Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levels | GCST90200033 | 1.81 |
| 2388 | Other arthropathies | musculoskeletal | UKBB00000601 | 1.81 |
| 2389 | CYTL1 levels | GCST90468940 | 1.81 |
| 2390 | CTSS levels | GCST90468916 | 1.81 |
| 2391 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T232 | ECGA000232 | 1.80 |
| 2392 | Constipation | FING00000348 | 1.80 |
| 2393 | Other chronic obstructive pulmonary disease | Chronic lower respiratory diseases | UKBB00000604 | 1.80 |
| 2394 | Free cholesterol in large LDL (UKB data field 23535) | GCST90269632 | 1.79 |
| 2395 | Omega-3 fatty acids to total fatty acids percentage | GCST90502463 | 1.79 |
| 2396 | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | GCST90004117 | 1.79 |
| 2397 | Cholesteryl esters to total lipids ratio in medium HDL | GCST90092895 | 1.79 |
| 2398 | IDP dMRI TBSS L3 Cingulum cingulate gyrus L | GCST90004206 | 1.78 |
| 2399 | FLT1/TGFB1 ratio | GCST90314857 | 1.78 |
| 2400 | CLIC5 levels | GCST90421740 | 1.78 |
| 2401 | Maximum workload during fitness test | ECG during exercise | UKBB00000432 | 1.78 |
| 2402 | Systolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000805 | 1.78 |
| 2403 | aparc-a2009s lh area G+S-subcentral | GCST90003300 | 1.77 |
| 2404 | Chronic rhinitis, nasopharyngitis and pharyngitis | FING00000297 | 1.77 |
| 2405 | Degree of unsaturation | GCST90502225 | 1.77 |
| 2406 | Age-related hearing impairment (MTAG) | GCST90012115 | 1.77 |
| 2407 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T321 | ECGU000321 | 1.77 |
| 2408 | FAM151A levels | GCST90242450 | 1.77 |
| 2409 | APOH levels | GCST90468340 | 1.77 |
| 2410 | Right-hemisphere control network to right-hemisphere default mode network white-matter structural connectivity | GCST90302835 | 1.76 |
| 2411 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T320 | ECGU000320 | 1.76 |
| 2412 | Lysoalkylphosphatidylcholine (O-24:1) levels | GCST90024198 | 1.76 |
| 2413 | Cholesterol to total lipids ratio in medium LDL | GCST90092905 | 1.76 |
| 2414 | Left ventricular end-systolic volume | GCST90268126 | 1.76 |
| 2415 | wg lh intensity-contrast superiorparietal | GCST90003820 | 1.76 |
| 2416 | Pulse rate, automated reading | Blood pressure | UKBB00000723 | 1.76 |
| 2417 | 1-methylhistidine levels | GCST90199691 | 1.76 |
| 2418 | DTI TBSS MD Anterior limb of internal capsule R | GCST90384588 | 1.75 |
| 2419 | rfMRI connectivity (ICA25 edge 103) | GCST90004746 | 1.75 |
| 2420 | Fracture of lumbar spine and pelvis | FING00000556 | 1.75 |
| 2421 | Biological Sibling: Cancer, Skin | GCST90476369 | 1.75 |
| 2422 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T52 | ECGU000052 | 1.75 |
| 2423 | GNS levels | GCST90088460 | 1.75 |
| 2424 | Hypertrophy of breast (Gynecomastia) (PheCode 612.2) | GCST90476163 | 1.74 |
| 2425 | Osteoarthrosis (PheCode 740) | GCST90476253 | 1.74 |
| 2426 | Acquired absence of organs, not elsewhere classified | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000005 | 1.74 |
| 2427 | aparc-a2009s lh area S-subparietal | GCST90003367 | 1.74 |
| 2428 | Prescriptions - selective beta1 antagonist|beta blocker | UKBB00000699 | 1.74 |
| 2429 | Skin sebum (glabella) | GCST90502797 | 1.73 |
| 2430 | 1-stearoyl-GPE (18:0) levels | GCST90199772 | 1.73 |
| 2431 | Multiple myeloma and malignant plasma cell neoplasms (controls excluding all cancers) | FING00000843 | 1.73 |
| 2432 | Total lipid levels in very large HDL | GCST90093010 | 1.73 |
| 2433 | IDP dMRI ProbtrackX MD ar l | GCST90004219 | 1.73 |
| 2434 | aparc-pial lh area caudalmiddlefrontal | GCST90003144 | 1.73 |
| 2435 | Indolelactate levels | GCST90243507 | 1.73 |
| 2436 | CLEC4D/HGF ratio | GCST90314110 | 1.73 |
| 2437 | CA2/UBAC1 ratio | GCST90313583 | 1.73 |
| 2438 | WAS levels | GCST90471071 | 1.72 |
| 2439 | IDP dMRI TBSS L1 External capsule R | GCST90004107 | 1.72 |
| 2440 | Free cholesterol levels in large HDL | GCST90092848 | 1.72 |
| 2441 | PSRC1 levels | GCST90470365 | 1.71 |
| 2442 | SLC51B levels | GCST90470664 | 1.71 |
| 2443 | Tetradecadienedioate (C14:2-DC) metabolite level | GCST90616275 | 1.71 |
| 2444 | Hemorrhagic fever with renal syndrome | GCST90454190 | 1.71 |
| 2445 | Mineral and other dietary supplements - Fish oil (including cod liver oil) | Medication | UKBB00000472 | 1.71 |
| 2446 | IDP dMRI ProbtrackX L3 fmi | GCST90004311 | 1.71 |
| 2447 | LDL (weighted GWA) | GCST90267273 | 1.71 |
| 2448 | PINLYP levels | GCST90470238 | 1.71 |
| 2449 | IgA nephropathy (IgA glomerulonephritis) | FING00000660 | 1.71 |
| 2450 | DTI TBSS FA Splenium of corpus callosum | GCST90384384 | 1.70 |
| 2451 | CDK8_CCNC levels | GCST90240825 | 1.70 |
| 2452 | HippSubfield lh volume hippocampal-fissure | GCST90002672 | 1.70 |
| 2453 | Right ventricular end diastolic volume | GCST90134588 | 1.70 |
| 2454 | Phospholipids in large HDL | GCST90497847 | 1.70 |
| 2455 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T234 | ECGU000234 | 1.70 |
| 2456 | IDP dMRI TBSS FA Splenium of corpus callosum | GCST90003881 | 1.70 |
| 2457 | IL17A levels | GCST90469558 | 1.69 |
| 2458 | aparc-a2009s lh volume S-postcentral | GCST90002991 | 1.69 |
| 2459 | Gamma-glutamylglycine levels | GCST90199741 | 1.68 |
| 2460 | Other diseases of blood and blood-forming organs, wide | FING00000999 | 1.68 |
| 2461 | SMNDC1 levels | GCST90470681 | 1.67 |
| 2462 | IDP dMRI TBSS L1 Uncinate fasciculus L | GCST90004120 | 1.67 |
| 2463 | aparc-Desikan rh volume parstriangularis | GCST90002820 | 1.67 |
| 2464 | BACH1/SNX9 ratio | GCST90313447 | 1.67 |
| 2465 | aparc-DKTatlas lh volume caudalmiddlefrontal | GCST90002864 | 1.67 |
| 2466 | Single spontaneous delivery | FING00001307 | 1.67 |
| 2467 | 1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) levels | GCST90200075 | 1.67 |
| 2468 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 83) | GCST90320646 | 1.67 |
| 2469 | DTI TBSS L3 Retrolenticular part of internal capsule L | GCST90384545 | 1.67 |
| 2470 | TGFBR2/TNFRSF19 ratio | GCST90315917 | 1.67 |
| 2471 | Phospholipids to total lipids in very small VLDL percentage (UKB data field 23604) | GCST90269701 | 1.66 |
| 2472 | Childhood maltreatment | GCST90551844 | 1.66 |
| 2473 | Systolic blood pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000806 | 1.66 |
| 2474 | IDP dMRI ProbtrackX L2 fmi | GCST90004284 | 1.66 |
| 2475 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T428 | ECGU000428 | 1.66 |
| 2476 | CFHR2 levels | GCST90468726 | 1.65 |
| 2477 | ITGA6/THPO ratio | GCST90315208 | 1.65 |
| 2478 | DTI autoptx FA atr l tract | GCST90385114 | 1.65 |
| 2479 | IDP dMRI TBSS ICVF Anterior limb of internal capsule R | GCST90004343 | 1.65 |
| 2480 | Propionylcarnitine levels | GCST90243593 | 1.65 |
| 2481 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T418 | ECGU000418 | 1.65 |
| 2482 | EFEMP1 levels | GCST90469078 | 1.64 |
| 2483 | Thyrotoxicosis with toxic multinodular goitre | FING00001362 | 1.64 |
| 2484 | CEP43/PLXNB3 ratio | GCST90314020 | 1.64 |
| 2485 | Cholesteryl esters to total lipids in large HDL percentage (UKB data field 23636) | GCST90269733 | 1.64 |
| 2486 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T366 | ECGU000366 | 1.64 |
| 2487 | Mean corpuscular hemoglobin variance | GCST90565693 | 1.64 |
| 2488 | Dementia, including avohilmo | FING00000395 | 1.64 |
| 2489 | Right-hemisphere dorsal attention network to hippocampus white-matter structural connectivity | GCST90302810 | 1.64 |
| 2490 | AK1 levels | GCST90468269 | 1.64 |
| 2491 | Orotidine levels | GCST90200681 | 1.64 |
| 2492 | SLAMF1 levels | GCST90470649 | 1.64 |
| 2493 | aparc-a2009s rh thickness G+S-cingul-Ant | GCST90003682 | 1.63 |
| 2494 | Undecenoylcarnitine (C11:1) levels | GCST90200236 | 1.63 |
| 2495 | ICD10 C50.9: Malignant neoplasm of breast of unspecified site | GCST90043889 | 1.63 |
| 2496 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T331 | ECGU000331 | 1.63 |
| 2497 | Cardiomyopathy (excluding other) | FING00000251 | 1.63 |
| 2498 | IDP dMRI ProbtrackX FA fmi | GCST90003936 | 1.62 |
| 2499 | Phosphatidylcholine diacyl C38:4 levels | GCST90240046 | 1.62 |
| 2500 | BA-exvivo rh volume BA6 | GCST90002855 | 1.62 |
| 2501 | Average log acceleration during the five least active hours of the day | GCST90061431 | 1.62 |
| 2502 | IDP dMRI TBSS OD External capsule R | GCST90004434 | 1.62 |
| 2503 | Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000440 | 1.62 |
| 2504 | Myristoyl dihydrosphingomyelin (d18:0/14:0) levels | GCST90200049 | 1.61 |
| 2505 | ESR1 levels | GCST90469155 | 1.61 |
| 2506 | QC dMRI-to-T1 linear alignment discrepancy | GCST90006351 | 1.61 |
| 2507 | Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457) | GCST90269554 | 1.61 |
| 2508 | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) levels | GCST90200067 | 1.61 |
| 2509 | IDP dMRI TBSS L3 Cingulum hippocampus L | GCST90004208 | 1.60 |
| 2510 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T438 | ECGU000438 | 1.60 |
| 2511 | PBXIP1 levels | GCST90470164 | 1.60 |
| 2512 | Congestive heart failure; nonhypertensive (PheCode 428) | GCST90475981 | 1.60 |
| 2513 | Ambidextrousness | GCST90013420 | 1.60 |
| 2514 | Total lipids in IDL (UKB data field 23524) | GCST90269621 | 1.60 |
| 2515 | Total cholesterol levels in HDL | GCST90132681 | 1.60 |
| 2516 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T476 | ECGA000476 | 1.59 |
| 2517 | Mean arterial pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000444 | 1.59 |
| 2518 | Ratio of monounsaturated fatty acids to total fatty acids | GCST90092929 | 1.59 |
| 2519 | Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers) | FING00000866 | 1.58 |
| 2520 | IDP dMRI ProbtrackX L2 ptr l | GCST90004292 | 1.58 |
| 2521 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T74 | ECGA000074 | 1.58 |
| 2522 | Physical activity (Total log acceleration 10pm-12am) | GCST90061420 | 1.58 |
| 2523 | Episcleritis | FING00000513 | 1.58 |
| 2524 | MTSS1 levels | GCST90469960 | 1.58 |
| 2525 | Speech-in-noise perception | GCST90044776 | 1.58 |
| 2526 | FADD/PPP1R2 ratio | GCST90314774 | 1.57 |
| 2527 | Acquired foot deformities | musculoskeletal | UKBB00000007 | 1.57 |
| 2528 | Red cell distribution width variance | GCST90565705 | 1.57 |
| 2529 | Takes medication for blood clot/ pulmonary embolism/ deep vein thrombosis (DVT)? | GCST90475210 | 1.57 |
| 2530 | low density lipoprotein cholesterol (LDLC, mean, inv-norm transformed) | GCST90475416 | 1.57 |
| 2531 | Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498926 | 1.57 |
| 2532 | BA-exvivo rh area BA45 | GCST90003229 | 1.57 |
| 2533 | Attention deficit hyperactivity disorder | GCST005362 | 1.57 |
| 2534 | PAEP levels | GCST90470144 | 1.57 |
| 2535 | Average diameter for LDL particles | GCST90092889 | 1.56 |
| 2536 | 1-palmitoyl-2-stearoyl-gpc (16:0/18:0) levels | GCST90200041 | 1.56 |
| 2537 | IDP dMRI TBSS L2 Posterior limb of internal capsule L | GCST90004142 | 1.55 |
| 2538 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T223 | ECGU000223 | 1.55 |
| 2539 | Docosahexaenoic acid levels | GCST90501984 | 1.55 |
| 2540 | Sources of admission to hospital (recoded) - Usual Place of residence | Summary Administration | UKBB00000786 | 1.55 |
| 2541 | Phospholipids in IDL (UKB data field 23525) | GCST90269622 | 1.55 |
| 2542 | IDP dMRI ProbtrackX MD ptr r | GCST90004239 | 1.55 |
| 2543 | Right-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivity | GCST90302821 | 1.55 |
| 2544 | F12 levels | GCST90469166 | 1.54 |
| 2545 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T233 | ECGA000233 | 1.54 |
| 2546 | IDP dMRI ProbtrackX L3 cgc r | GCST90004305 | 1.54 |
| 2547 | Spatial QRS-T angle | GCST90246320 | 1.53 |
| 2548 | PGLYRP2 levels | GCST90470220 | 1.53 |
| 2549 | CCL4 levels | GCST90274770 | 1.53 |
| 2550 | Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000439 | 1.53 |
| 2551 | Blood cell traits latent factor 4 (red cell) | GCST90559246 | 1.53 |
| 2552 | IDP dMRI ProbtrackX L1 unc r | GCST90004272 | 1.52 |
| 2553 | FN1 levels | GCST90469255 | 1.52 |
| 2554 | Retinal vascular disorders | FING00001262 | 1.52 |
| 2555 | IDP dMRI TBSS L3 External capsule L | GCST90004204 | 1.52 |
| 2556 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T333 | ECGU000333 | 1.52 |
| 2557 | Right-hemisphere dorsal attention network to amygdala white-matter structural connectivity | GCST90302811 | 1.52 |
| 2558 | Blood cell traits latent factor 13 (red cell) | GCST90559255 | 1.52 |
| 2559 | HJV levels | GCST90469455 | 1.52 |
| 2560 | IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L | GCST90004166 | 1.52 |
| 2561 | Left-hemisphere somatomotor network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302678 | 1.52 |
| 2562 | Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae) | GCST90027668 | 1.52 |
| 2563 | Cereal bar liking | GCST90094728 | 1.51 |
| 2564 | Low back pain | FING00000730 | 1.51 |
| 2565 | DTI autoptx L3 unc r tract | GCST90385219 | 1.51 |
| 2566 | COL9A1 levels | GCST90468822 | 1.51 |
| 2567 | heart rate (HR, minimum, inv-normal transformed) | GCST90476341 | 1.50 |
| 2568 | 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levels | GCST90199649 | 1.50 |
| 2569 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T205 | ECGU000205 | 1.50 |
| 2570 | LDL (standard GWA) | GCST90267272 | 1.50 |
| 2571 | IDP dMRI ProbtrackX MD ilf l | GCST90004233 | 1.50 |
| 2572 | Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+NH4]1+ levels | GCST90060325 | 1.50 |
| 2573 | SERPINA3 levels | GCST90470583 | 1.50 |
| 2574 | Encounter for long-term (current) use of anticoagulants (PheCode 286.2) | GCST90475799 | 1.50 |
| 2575 | Impedance of leg (right) | Impedance measures | UKBB00000359 | 1.50 |
| 2576 | Glycerate levels | GCST90200290 | 1.49 |
| 2577 | MYLPF levels | GCST90469980 | 1.49 |
| 2578 | T1 FreeSurfer DKT rh fusiform thickness | GCST90384322 | 1.49 |
| 2579 | Alzheimer's disease | GCST90027158 | 1.49 |
| 2580 | QC tfMRI-to-T1 linear alignment discrepancy | GCST90006354 | 1.49 |
| 2581 | aparc-a2009s rh volume G-postcentral | GCST90003026 | 1.49 |
| 2582 | Hearing difficulty/problems | Hearing | UKBB00000310 | 1.49 |
| 2583 | DPP6/SEZ6L ratio | GCST90314544 | 1.49 |
| 2584 | 2-aminobutyrate levels | GCST90243584 | 1.49 |
| 2585 | IDP dMRI TBSS MD Uncinate fasciculus L | GCST90004072 | 1.49 |
| 2586 | Holdemania abundance in stool | GCST90032432 | 1.48 |
| 2587 | Beta-hydroxyisovaleroylcarnitine levels | GCST90199802 | 1.48 |
| 2588 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T475 | ECGA000475 | 1.48 |
| 2589 | T1 FreeSurfer BA lh BA3a exvivo thickness | GCST90385521 | 1.48 |
| 2590 | Femoral hernia | FING00000540 | 1.47 |
| 2591 | METAP1D/PLXNA4 ratio | GCST90315427 | 1.47 |
| 2592 | Biological Father: Chronic Lung Disease including COPD, Emphysema or Bronchitis | GCST90475247 | 1.47 |
| 2593 | GDF15 levels | GCST90469321 | 1.47 |
| 2594 | PPP1R14A levels | GCST90470302 | 1.46 |
| 2595 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T324 | ECGU000324 | 1.46 |
| 2596 | OXT levels | GCST90470139 | 1.46 |
| 2597 | Visual disturbances | FING00001437 | 1.46 |
| 2598 | IDP dMRI ProbtrackX L3 ilf l | GCST90004314 | 1.46 |
| 2599 | LEP levels | GCST90469757 | 1.46 |
| 2600 | FKBP5/MAP4K5 ratio | GCST90314843 | 1.46 |
| 2601 | Triglyceride levels in chylomicrons and extremely large VLDL | GCST90132630 | 1.46 |
| 2602 | IDP T1 FAST ROIs R cerebellum V | GCST90002565 | 1.45 |
| 2603 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T79 | ECGU000079 | 1.45 |
| 2604 | IDP dMRI TBSS MD Superior corona radiata R | GCST90004051 | 1.45 |
| 2605 | IDP dMRI ProbtrackX L2 ifo r | GCST90004286 | 1.45 |
| 2606 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T201 | ECGU000201 | 1.45 |
| 2607 | Brainstem global volume Medulla | GCST90002764 | 1.45 |
| 2608 | Disorders of lipoprotein metabolism and other lipidaemias | Metabolic disorders | UKBB00000186 | 1.44 |
| 2609 | Sphingomyelin_42:2_[M+OAc]1- levels | GCST90060507 | 1.44 |
| 2610 | IDP dMRI TBSS MD Superior cerebellar peduncle R | GCST90004039 | 1.44 |
| 2611 | ATF6 levels | GCST90617260 | 1.44 |
| 2612 | Phospholipids to total lipids ratio in large HDL | GCST90092853 | 1.44 |
| 2613 | Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000436 | 1.44 |
| 2614 | aparc-Desikan rh area parstriangularis | GCST90003126 | 1.44 |
| 2615 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T326 | ECGU000326 | 1.44 |
| 2616 | AXIN1/DOK2 ratio | GCST90313406 | 1.44 |
| 2617 | IDP dMRI TBSS FA Superior fronto-occipital fasciculus L | GCST90003920 | 1.44 |
| 2618 | DTI TBSS MD External capsule R | GCST90384604 | 1.44 |
| 2619 | ABHD14B levels | GCST90468189 | 1.43 |
| 2620 | Type 2 diabetes, wide definition | FING00001383 | 1.43 |
| 2621 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T365 | ECGU000365 | 1.43 |
| 2622 | Mineral and other dietary supplements - None of the above | Medication | UKBB00000474 | 1.42 |
| 2623 | Dihomo-linoleoylcarnitine (C20:2) levels | GCST90200144 | 1.42 |
| 2624 | Noninflammatory disorders of female genital tract | FING00000882 | 1.42 |
| 2625 | Urticaria | GCST90018716 | 1.42 |
| 2626 | Right-hemisphere limbic network to putamen white-matter structural connectivity | GCST90302829 | 1.42 |
| 2627 | C1QTNF1/COL4A1 ratio | GCST90313552 | 1.42 |
| 2628 | aparc-pial lh area precuneus | GCST90003165 | 1.42 |
| 2629 | IDP dMRI TBSS MD Cingulum cingulate gyrus R | GCST90004061 | 1.42 |
| 2630 | Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae.g_Alistipes) | GCST90027701 | 1.41 |
| 2631 | Right ventricular end diastolic volume (MTAG) | GCST90134592 | 1.41 |
| 2632 | Osteopenia or other disorder of bone and cartilage (PheCode 743.9) | GCST90476261 | 1.41 |
| 2633 | aseg global volume SupraTentorial | GCST90002595 | 1.41 |
| 2634 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T357 | ECGU000357 | 1.41 |
| 2635 | Methods of discharge from hospital (recoded) - Discharged on clinical advice/consent | Summary Administration | UKBB00000466 | 1.41 |
| 2636 | TP53I3 levels | GCST90470937 | 1.40 |
| 2637 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T29 | ECGU000029 | 1.40 |
| 2638 | CD99L2/RARRES2 ratio | GCST90313927 | 1.40 |
| 2639 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T344 | ECGU000344 | 1.40 |
| 2640 | IDP dMRI ProbtrackX L3 unc r | GCST90004326 | 1.40 |
| 2641 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T362 | ECGU000362 | 1.39 |
| 2642 | IDP dMRI TBSS FA Superior cerebellar peduncle R | GCST90003889 | 1.39 |
| 2643 | IDP dMRI TBSS MD Superior fronto-occipital fasciculus R | GCST90004069 | 1.39 |
| 2644 | RNASE4 levels | GCST90470478 | 1.39 |
| 2645 | Usual side of head for mobile phone use - Equally left and right | Electronic device use | UKBB00000888 | 1.39 |
| 2646 | wg rh intensity-contrast superiorparietal | GCST90003855 | 1.39 |
| 2647 | Liver volume (adjusted for height) | GCST90566819 | 1.38 |
| 2648 | BA-exvivo rh area BA6 | GCST90003227 | 1.38 |
| 2649 | Modified Stumvoll Insulin Sensitivity Index (adjusted for BMI) | GCST90267573 | 1.38 |
| 2650 | BA-exvivo rh volume BA45 | GCST90002857 | 1.38 |
| 2651 | LAT/LYN ratio | GCST90315283 | 1.38 |
| 2652 | Glucose levels | GCST90132724 | 1.37 |
| 2653 | CD99 levels | GCST90468658 | 1.37 |
| 2654 | Left-hemisphere default mode network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302762 | 1.37 |
| 2655 | DSG2 levels | GCST90423766 | 1.37 |
| 2656 | Free cholesterol levels in HDL | GCST90092824 | 1.37 |
| 2657 | BA-exvivo rh area BA2 | GCST90003222 | 1.37 |
| 2658 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T361 | ECGU000361 | 1.36 |
| 2659 | Liver volume | GCST90566818 | 1.36 |
| 2660 | INPP1/TBCC ratio | GCST90315180 | 1.36 |
| 2661 | Ulcerative enterocolitis | FING00001391 | 1.36 |
| 2662 | GBP4 levels | GCST90469313 | 1.35 |
| 2663 | Cardiorespiratory fitness (vo2 max) | GCST90093316 | 1.35 |
| 2664 | Alcohol-related disorders | mental disorders | UKBB00000026 | 1.35 |
| 2665 | IDP dMRI TBSS MO Cerebral peduncle R | GCST90003966 | 1.35 |
| 2666 | COMP/TGFBI ratio | GCST90314192 | 1.35 |
| 2667 | Hearing difficulty/problems | Hearing | UKBB00000311 | 1.35 |
| 2668 | Free Cholesterol to Total Lipids in Small LDL percentage | GCST90499635 | 1.35 |
| 2669 | Plasma sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0)* levels in chronic kidney disease | GCST90265971 | 1.35 |
| 2670 | FAM13A levels | GCST90469181 | 1.35 |
| 2671 | Degree of unsaturation | GCST90502736 | 1.35 |
| 2672 | Treatment/medication code - aspirin | Medications | UKBB00000841 | 1.34 |
| 2673 | ICD10 N80: Endometriosis | GCST90454213 | 1.34 |
| 2674 | RNASEH2A levels | GCST90470480 | 1.34 |
| 2675 | Lysophosphatidylcholine (22:0) [sn2] levels | GCST90024176 | 1.34 |
| 2676 | Saturated fatty acids to total fatty acids percentage | GCST90502684 | 1.34 |
| 2677 | aparc-a2009s lh thickness G-precuneus | GCST90003632 | 1.34 |
| 2678 | Total free cholesterol levels | GCST90500072 | 1.34 |
| 2679 | Arterial stiffness index | GCST008403 | 1.34 |
| 2680 | TNFSF10 levels | GCST90274843 | 1.34 |
| 2681 | IDP dMRI TBSS OD Superior fronto-occipital fasciculus R | GCST90004444 | 1.33 |
| 2682 | heart rate (HR, maximum, inv-normal transformed) | GCST90476334 | 1.33 |
| 2683 | ATXN10/PRTFDC1 ratio | GCST90313398 | 1.33 |
| 2684 | Educational attainment | GCST002598 | 1.33 |
| 2685 | IDP dMRI TBSS MD Superior longitudinal fasciculus R | GCST90004067 | 1.33 |
| 2686 | Total cholesterol levels | GCST90500022 | 1.33 |
| 2687 | Cholesteryl ester levels in very small VLDL | GCST90093030 | 1.33 |
| 2688 | Insulin pump user (PheCode 250.3) | GCST90475680 | 1.33 |
| 2689 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T234 | ECGA000234 | 1.33 |
| 2690 | Aneurysm of iliac artery (PheCode 442.2) | GCST90475995 | 1.32 |
| 2691 | Right ventricular stroke volume (MTAG) | GCST90134594 | 1.32 |
| 2692 | SPOCK1 levels | GCST90470730 | 1.32 |
| 2693 | Free Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500398 | 1.32 |
| 2694 | acne vulgaris | GCST90245818 | 1.32 |
| 2695 | IDP dMRI ProbtrackX FA ar l | GCST90003925 | 1.32 |
| 2696 | CNTN3/NCS1 ratio | GCST90314165 | 1.32 |
| 2697 | FGF5 levels | GCST90469226 | 1.31 |
| 2698 | IDP dMRI TBSS ICVF Superior cerebellar peduncle R | GCST90004339 | 1.31 |
| 2699 | Skin brightness | GCST90502777 | 1.31 |
| 2700 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T283 | ECGA000283 | 1.31 |
| 2701 | Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000435 | 1.31 |
| 2702 | Phospholipids to total lipids in large HDL percentage (UKB data field 23634) | GCST90269731 | 1.31 |
| 2703 | mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed) | GCST90475462 | 1.31 |
| 2704 | aparc-Desikan lh volume caudalmiddlefrontal | GCST90002771 | 1.31 |
| 2705 | IGFBP3 levels | GCST90102624 | 1.31 |
| 2706 | Free cholesterol in LDL (UKB data field 23421) | GCST90269518 | 1.30 |
| 2707 | Endometriosis of pelvic peritoneum | FING00000502 | 1.30 |
| 2708 | LYZL2 levels | GCST90469833 | 1.30 |
| 2709 | Right-hemisphere somatomotor network to hippocampus white-matter structural connectivity | GCST90302798 | 1.29 |
| 2710 | Pancreas fat | GCST90016675 | 1.29 |
| 2711 | Anaphylactic shock due to adverse effect of correct drug or medication properly administered | FING00000084 | 1.29 |
| 2712 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T429 | ECGU000429 | 1.29 |
| 2713 | ARG1 levels | GCST90468350 | 1.29 |
| 2714 | Enteritis due to Yersinia enterocolitica | FING00000505 | 1.29 |
| 2715 | CDKN1A/FOXO1 ratio | GCST90313970 | 1.29 |
| 2716 | IDP dMRI TBSS MD Sagittal stratum R | GCST90004057 | 1.29 |
| 2717 | Non-cancer illness code, self-reported - angina | Medical conditions | UKBB00000505 | 1.29 |
| 2718 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T465 | ECGA000465 | 1.29 |
| 2719 | Mental and behavioural disorders due to use of other stimulants, including caffeine | FING00000811 | 1.29 |
| 2720 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T477 | ECGA000477 | 1.29 |
| 2721 | DTI autoptx FA atr r tract | GCST90385115 | 1.28 |
| 2722 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T426 | ECGU000426 | 1.28 |
| 2723 | CA2/PSMG3 ratio | GCST90313581 | 1.28 |
| 2724 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T235 | ECGA000235 | 1.28 |
| 2725 | TOP1 levels | GCST90470933 | 1.28 |
| 2726 | Pain type(s) experienced in last month - Neck or shoulder pain | Pain | UKBB00000630 | 1.28 |
| 2727 | Autorefraction - 3mm asymmetry angle (left) | Eyesight | UKBB00000060 | 1.28 |
| 2728 | Ectopic pregnancy | GCST90272883 | 1.27 |
| 2729 | Cardiac dysrhythmias | circulatory system | UKBB00000119 | 1.27 |
| 2730 | REST UKBBICA NODEamps25 0005 | GCST90385488 | 1.27 |
| 2731 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T55 | ECGU000055 | 1.27 |
| 2732 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T125 | ECGU000125 | 1.27 |
| 2733 | Number of sexual partners in opposite-sex sexual behavior | GCST90026482 | 1.27 |
| 2734 | Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000809 | 1.27 |
| 2735 | ICD10 O00: Ectopic pregnancy | GCST90454227 | 1.27 |
| 2736 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T70 | ECGA000070 | 1.27 |
| 2737 | aseg global volume SupraTentorialNotVent | GCST90002596 | 1.27 |
| 2738 | Concentration of very large HDL particles | GCST90500431 | 1.27 |
| 2739 | IGLL1 levels | GCST90241473 | 1.26 |
| 2740 | COPD | FING00000350 | 1.26 |
| 2741 | Disorders of lipoid metabolism | endocrine/metabolic | UKBB00000185 | 1.26 |
| 2742 | Hyperlipidemia | endocrine/metabolic | UKBB00000333 | 1.26 |
| 2743 | Phospholipids in very large HDL | GCST90500458 | 1.26 |
| 2744 | Total esterified cholesterol levels | GCST90092986 | 1.26 |
| 2745 | CCL16 levels | GCST90468568 | 1.26 |
| 2746 | Esophageal cancer | GCST90018621 | 1.26 |
| 2747 | Phospholipids to Total Lipids in Very Large HDL percentage | GCST90500474 | 1.26 |
| 2748 | All dysplastic lesions of the cervix uteri, vagina or vulva | FING00000061 | 1.26 |
| 2749 | wg rh intensity-contrast caudalmiddlefrontal | GCST90003830 | 1.26 |
| 2750 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T190 | ECGU000190 | 1.25 |
| 2751 | Free Cholesterol to Total Lipids in Medium LDL percentage | GCST90498784 | 1.25 |
| 2752 | NPTXR levels | GCST90470080 | 1.24 |
| 2753 | NT5C3A levels | GCST90470091 | 1.24 |
| 2754 | Multiple myeloma | GCST90624747 | 1.24 |
| 2755 | ANGPTL2 levels | GCST90468303 | 1.24 |
| 2756 | Benign paroxysmal vertigo | FING00000210 | 1.24 |
| 2757 | Lawsonibacter sp002161175 abundance in stool | GCST90032459 | 1.24 |
| 2758 | Hand grip strength (left) | Hand grip strength | UKBB00000300 | 1.24 |
| 2759 | PRND levels | GCST90470333 | 1.24 |
| 2760 | DARS1/MAP4K5 ratio | GCST90314404 | 1.24 |
| 2761 | IDP T1 SIENAX grey unnormalised volume | GCST90002431 | 1.23 |
| 2762 | IDP dMRI TBSS MD Middle cerebellar peduncle | GCST90004027 | 1.23 |
| 2763 | ATOX1/SPARC ratio | GCST90313375 | 1.23 |
| 2764 | wg rh intensity-contrast cuneus | GCST90003831 | 1.23 |
| 2765 | Total esterified cholesterol levels (UKB data field 23415) | GCST90269512 | 1.23 |
| 2766 | PADI4 levels | GCST90470143 | 1.22 |
| 2767 | aparc-a2009s rh area S-oc-temp-med+Lingual | GCST90003431 | 1.22 |
| 2768 | FOLH1 levels | GCST90241272 | 1.22 |
| 2769 | Plasma X-24544 levels in chronic kidney disease | GCST90266757 | 1.22 |
| 2770 | Emotional abuse | GCST90551845 | 1.22 |
| 2771 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T360 | ECGU000360 | 1.22 |
| 2772 | TPI1 levels | GCST90088659 | 1.22 |
| 2773 | CTSH levels | GCST90468913 | 1.22 |
| 2774 | ICD10 N97.0: Female infertility associated with anovulation | GCST90454223 | 1.22 |
| 2775 | Cholesteryl Esters in Large LDL | GCST90497955 | 1.22 |
| 2776 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T484 | ECGA000484 | 1.21 |
| 2777 | Inpatient record format - UK HES Inpatients (2017 format) | Summary Administration | UKBB00000365 | 1.21 |
| 2778 | Allergy/adverse effect of penicillin | injuries & poisonings | UKBB00000028 | 1.21 |
| 2779 | Total lipid levels in large LDL | GCST90092862 | 1.21 |
| 2780 | Noninfectious gastroenteritis | digestive | UKBB00000526 | 1.21 |
| 2781 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T236 | ECGU000236 | 1.21 |
| 2782 | Liver proton density fat fraction | GCST90267352 | 1.21 |
| 2783 | HippSubfield rh volume Hippocampal-tail | GCST90002690 | 1.21 |
| 2784 | IDP T1 SIENAX grey normalised volume | GCST90002430 | 1.21 |
| 2785 | AHNAK2 levels | GCST90468260 | 1.21 |
| 2786 | IDP dMRI ProbtrackX L2 cgc r | GCST90004278 | 1.21 |
| 2787 | COL1A1 levels | GCST90240744 | 1.21 |
| 2788 | Docosahexaenoic acid to total fatty acids percentage | GCST90502281 | 1.21 |
| 2789 | Early age-related macular degeneration | GCST010723 | 1.20 |
| 2790 | rfMRI connectivity (ICA100 edge 659) | GCST90005512 | 1.20 |
| 2791 | CPPED1 levels | GCST90468845 | 1.20 |
| 2792 | Lichen ruber planus, wide definition including periferal and oral lichen planus | FING00000722 | 1.20 |
| 2793 | CCER2 levels | GCST90468563 | 1.20 |
| 2794 | aparc-a2009s lh volume S-central | GCST90002969 | 1.20 |
| 2795 | CASP10/PRTFDC1 ratio | GCST90313627 | 1.20 |
| 2796 | Retention of urine (PheCode 599.2) | GCST90476150 | 1.20 |
| 2797 | SSC4D/TNFSF10 ratio | GCST90315887 | 1.20 |
| 2798 | Phenylalanine levels | GCST90243407 | 1.20 |
| 2799 | Other abnormal uterine and vaginal bleeding | FING00000919 | 1.20 |
| 2800 | Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523 | FING00000304 | 1.20 |
| 2801 | IDP dMRI ProbtrackX ICVF cst l | GCST90004383 | 1.19 |
| 2802 | Systolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000804 | 1.19 |
| 2803 | Hypertension | GCST90086092 | 1.19 |
| 2804 | RHOC/TBCB ratio | GCST90315774 | 1.19 |
| 2805 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T474 | ECGA000474 | 1.18 |
| 2806 | Takes medication for skin cancer? | GCST90475190 | 1.18 |
| 2807 | aparc-a2009s rh area G-oc-temp-lat-fusifor | GCST90003391 | 1.18 |
| 2808 | rfMRI connectivity (ICA100 edge 614) | GCST90005467 | 1.18 |
| 2809 | Other disorders of synovium, tendon, and bursa (PheCode 727) | GCST90476241 | 1.18 |
| 2810 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T358 | ECGU000358 | 1.18 |
| 2811 | GPIHBP1 levels | GCST90469390 | 1.18 |
| 2812 | Clinical LDL cholesterol levels | GCST90497223 | 1.18 |
| 2813 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T332 | ECGU000332 | 1.18 |
| 2814 | Osteoporosis | FING00000914 | 1.18 |
| 2815 | Viral haemorrhagic fevers, not elsewhere classified/unspecified | FING00001433 | 1.18 |
| 2816 | Addison's disease | GCST90011871 | 1.18 |
| 2817 | EIF4G1/FKBP5 ratio | GCST90314633 | 1.18 |
| 2818 | Left-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302658 | 1.18 |
| 2819 | Principal component-derived dietary pattern 32 | GCST90133037 | 1.17 |
| 2820 | GAST levels | GCST90469307 | 1.17 |
| 2821 | Non-cancer illness code, self-reported - hiatus hernia | Medical conditions | UKBB00000515 | 1.17 |
| 2822 | FGA levels | GCST90469216 | 1.17 |
| 2823 | ALCAM/NOTCH1 ratio | GCST90313241 | 1.17 |
| 2824 | FABP4 levels | GCST90469176 | 1.16 |
| 2825 | Pre-eclampsia or poor fetal growth | FING00001202 | 1.16 |
| 2826 | Length of working week for main job | Employment | UKBB00000405 | 1.16 |
| 2827 | Myasthenia gravis | GCST90432156 | 1.16 |
| 2828 | Gallbladder polyp | GCST90018626 | 1.16 |
| 2829 | Left-hemisphere limbic network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302731 | 1.16 |
| 2830 | aparc-DKTatlas rh area parsopercularis | GCST90003281 | 1.15 |
| 2831 | Total lipids in very large HDL | GCST90500410 | 1.15 |
| 2832 | IDP dMRI ProbtrackX ICVF ml l | GCST90004392 | 1.15 |
| 2833 | APP/CD40LG ratio | GCST90313319 | 1.15 |
| 2834 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T236 | ECGA000236 | 1.15 |
| 2835 | Reticulocyte count | Blood count | UKBB00000752 | 1.15 |
| 2836 | wg rh intensity-contrast bankssts | GCST90003828 | 1.15 |
| 2837 | IDP dMRI ProbtrackX OD str r | GCST90004474 | 1.14 |
| 2838 | Normal-pressure hydrocephalus | FING00000891 | 1.14 |
| 2839 | Medication use (beta blocking agents) | GCST90018766 | 1.14 |
| 2840 | GPD1 levels | GCST90469388 | 1.14 |
| 2841 | Total cholesterol minus HDL-C levels | GCST90499130 | 1.14 |
| 2842 | MNX1 levels | GCST90090758 | 1.14 |
| 2843 | Functional dyspepsia | FING00000561 | 1.14 |
| 2844 | Polycystic ovarian syndrome, broad definition | FING00001183 | 1.14 |
| 2845 | COL6A3/HSPG2 ratio | GCST90314175 | 1.14 |
| 2846 | Phospholipids in LDL | GCST90498439 | 1.14 |
| 2847 | Prescriptions - antipyretic | UKBB00000665 | 1.14 |
| 2848 | Prescriptions - paracetamol | antipyretic | UKBB00000696 | 1.14 |
| 2849 | Waist-to-Hip ratio | Body measurement | UKBB00000905 | 1.14 |
| 2850 | Medication use (drugs used in diabetes) | GCST90018761 | 1.14 |
| 2851 | CA1/CA3 ratio | GCST90313572 | 1.14 |
| 2852 | MMP8/PGLYRP1 ratio | GCST90315465 | 1.13 |
| 2853 | Prescriptions - sulfonylurea|diabetes | UKBB00000703 | 1.13 |
| 2854 | Acetate levels (UKB data field 23475) | GCST90269572 | 1.13 |
| 2855 | Other and unspecified urticaria | FING00000957 | 1.13 |
| 2856 | Ceramide (d18:1/24:0) levels | GCST90024046 | 1.13 |
| 2857 | SNAP23/TXLNA ratio | GCST90315857 | 1.13 |
| 2858 | PTPRN2 levels | GCST90470385 | 1.13 |
| 2859 | Phosphatidylethanolamine (38:4) levels | GCST90488261 | 1.13 |
| 2860 | Atrial fibrillation and flutter (PheCode 427.2) | GCST90475967 | 1.12 |
| 2861 | rfMRI connectivity ICA-features 6 | GCST90006344 | 1.12 |
| 2862 | APOA2 levels | GCST90468332 | 1.12 |
| 2863 | Prescriptions - latanoprost | prostaglandin analog | UKBB00000686 | 1.12 |
| 2864 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T425 | ECGU000425 | 1.12 |
| 2865 | IDP dMRI TBSS L3 Posterior corona radiata L | GCST90004198 | 1.12 |
| 2866 | IDP dMRI TBSS ICVF Sagittal stratum L | GCST90004358 | 1.12 |
| 2867 | Cholelithiasis | digestive | UKBB00000131 | 1.12 |
| 2868 | Radiotherapy (PheCode 196) | GCST90475605 | 1.12 |
| 2869 | Free cholesterol levels in medium HDL | GCST90092896 | 1.12 |
| 2870 | Low hand grip strength (60 years and older) (FNIH) | GCST90007529 | 1.12 |
| 2871 | aparc-Desikan rh volume parahippocampal | GCST90002816 | 1.11 |
| 2872 | HippSubfield rh volume presubiculum-body | GCST90002697 | 1.11 |
| 2873 | aparc-Desikan lh area lingual | GCST90003085 | 1.11 |
| 2874 | aparc-DKTatlas rh volume parsopercularis | GCST90002909 | 1.11 |
| 2875 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T427 | ECGU000427 | 1.11 |
| 2876 | Myocardial fractal dimension (slice 3) | GCST90000289 | 1.11 |
| 2877 | DTI TBSS L1 Splenium of corpus callosum | GCST90384432 | 1.11 |
| 2878 | Free cholesterol in small HDL | GCST90499425 | 1.11 |
| 2879 | X-17676 levels | GCST90200548 | 1.11 |
| 2880 | LDL cholesterol levels | GCST90498353 | 1.11 |
| 2881 | Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500324 | 1.11 |
| 2882 | Glycerophosphorylcholine (GPC) levels | GCST90199629 | 1.11 |
| 2883 | Melanomas of skin (PheCode 172.11) | GCST90475578 | 1.10 |
| 2884 | Asphyxia and hypoxemia (PheCode 1013) | GCST90475559 | 1.10 |
| 2885 | Systolic blood pressure | GCST90278642 | 1.10 |
| 2886 | Prescriptions - losartan | angiotensin receptor blocker,anti-hypertensive,ARB | UKBB00000690 | 1.10 |
| 2887 | Nummular dermatitis | FING00000893 | 1.10 |
| 2888 | wg rh intensity-contrast pericalcarine | GCST90003847 | 1.10 |
| 2889 | T1 FreeSurfer a2009s rh G&S subcentral volume | GCST90385041 | 1.10 |
| 2890 | IDP dMRI TBSS L3 Posterior corona radiata R | GCST90004197 | 1.10 |
| 2891 | Internal derangement of knee (PheCode 835) | GCST90476282 | 1.10 |
| 2892 | UBA9475 sp002161235 abundance in stool | GCST90032635 | 1.10 |
| 2893 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T221 | ECGA000221 | 1.09 |
| 2894 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T356 | ECGU000356 | 1.09 |
| 2895 | IDP T1 FAST ROIs R parietal operc cortex | GCST90002536 | 1.09 |
| 2896 | Phospholipids in medium VLDL | GCST90499025 | 1.09 |
| 2897 | Left ventricular end systole inferolateral wall thickness | GCST90278510 | 1.09 |
| 2898 | X-24337 levels | GCST90200629 | 1.09 |
| 2899 | 1-stearoyl-gpc (18:0) levels | GCST90199732 | 1.09 |
| 2900 | DTI autoptx L1 atr r tract | GCST90385142 | 1.09 |
| 2901 | Free cholesterol to total lipids ratio in very large HDL | GCST90093009 | 1.09 |
| 2902 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T235 | ECGU000235 | 1.09 |
| 2903 | Hereditary deficiency of other clotting factors | FING00000612 | 1.09 |
| 2904 | DTI autoptx L2 ptr l tract | GCST90385185 | 1.09 |
| 2905 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T200 | ECGU000200 | 1.09 |
| 2906 | PTGR1 levels | GCST90470370 | 1.09 |
| 2907 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T204 | ECGU000204 | 1.09 |
| 2908 | low density lipoprotein cholesterol (LDLC, minimum, inv-norm transformed) | GCST90475420 | 1.09 |
| 2909 | DTI autoptx MD cgc r tract | GCST90385225 | 1.08 |
| 2910 | CD84 levels | GCST90468653 | 1.08 |
| 2911 | IDP dMRI ProbtrackX MD unc r | GCST90004245 | 1.08 |
| 2912 | IDP dMRI TBSS ISOVF Anterior corona radiata R | GCST90004499 | 1.08 |
| 2913 | aseg lh intensity Thalamus-Proper | GCST90003768 | 1.08 |
| 2914 | Other predominantly sexually transmitted diseases, not elsewhere classified | FING00001089 | 1.08 |
| 2915 | Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000808 | 1.08 |
| 2916 | Ischemic Heart Disease | circulatory system | UKBB00000381 | 1.07 |
| 2917 | Alcohol intake versus 10 years previously | Alcohol | UKBB00000024 | 1.07 |
| 2918 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T488 | ECGA000488 | 1.07 |
| 2919 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T354 | ECGU000354 | 1.07 |
| 2920 | ITIH3/VCAM1 ratio | GCST90315236 | 1.07 |
| 2921 | IDP dMRI TBSS ICVF Posterior thalamic radiation R | GCST90004355 | 1.07 |
| 2922 | Personal history of medical treatment | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000643 | 1.07 |
| 2923 | Substance use, excluding alcohol | FING00001342 | 1.07 |
| 2924 | Mean volume of bilateral amygdala | GCST90474899 | 1.07 |
| 2925 | CDKN1A/FXN ratio | GCST90313971 | 1.07 |
| 2926 | Treatment/medication code - simvastatin | Medications | UKBB00000859 | 1.06 |
| 2927 | FKBP5/TBCC ratio | GCST90314849 | 1.06 |
| 2928 | ITGB5/VSIR ratio | GCST90315235 | 1.06 |
| 2929 | DTI autoptx L2 atr l tract | GCST90385168 | 1.06 |
| 2930 | GOLM2 levels | GCST90469376 | 1.06 |
| 2931 | Tiglylcarnitine (C5:1-DC) levels | GCST90199800 | 1.06 |
| 2932 | Other arrhythmias | FING00000962 | 1.06 |
| 2933 | Principal component-derived dietary pattern 40 | GCST90133045 | 1.06 |
| 2934 | IDP dMRI ProbtrackX FA unc r | GCST90003951 | 1.05 |
| 2935 | Cardiac arrhythmias | FING00000248 | 1.05 |
| 2936 | Medication use (antihypertensives) | GCST90018764 | 1.05 |
| 2937 | Plasma 4-guanidinobutanoate levels in chronic kidney disease | GCST90264620 | 1.05 |
| 2938 | BLVRB/CA1 ratio | GCST90313521 | 1.05 |
| 2939 | Left-hemisphere default mode network to caudate white-matter structural connectivity | GCST90302768 | 1.05 |
| 2940 | Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers) | FING00000777 | 1.05 |
| 2941 | Vascular/heart problems diagnosed by doctor - Angina | Medical conditions | UKBB00000896 | 1.05 |
| 2942 | RSPO1/SFRP1 ratio | GCST90315791 | 1.05 |
| 2943 | Gestational age at birth (maternal effect) | GCST90268419 | 1.05 |
| 2944 | Glaucoma (PheCode 365) | GCST008373 | 1.05 |
| 2945 | Other chronic ischemic heart disease, unspecified | circulatory system | UKBB00000603 | 1.05 |
| 2946 | Cholesterol in large LDL (UKB data field 23533) | GCST90269630 | 1.04 |
| 2947 | SSC5D levels | GCST90470748 | 1.04 |
| 2948 | DEFA1_DEFA1B/PTGDS ratio | GCST90314455 | 1.04 |
| 2949 | MMP10 levels | GCST90469915 | 1.04 |
| 2950 | Impedance of whole body | Impedance measures | UKBB00000360 | 1.04 |
| 2951 | IDP dMRI TBSS ICVF Posterior corona radiata L | GCST90004354 | 1.04 |
| 2952 | Dorsalgia | FING00000472 | 1.04 |
| 2953 | DDX58 levels | GCST90468977 | 1.04 |
| 2954 | N-acetylcarnosine levels | GCST90199926 | 1.04 |
| 2955 | Diastolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000182 | 1.04 |
| 2956 | LCN2/PGLYRP1 ratio | GCST90315306 | 1.04 |
| 2957 | aparc-a2009s rh area G-occipital-sup | GCST90003390 | 1.04 |
| 2958 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 112) | GCST90320931 | 1.04 |
| 2959 | Right-hemisphere somatomotor network to putamen white-matter structural connectivity | GCST90302796 | 1.04 |
| 2960 | Unstable angina (intermediate coronary syndrome) | circulatory system | UKBB00000883 | 1.04 |
| 2961 | NRP1 levels | GCST90470085 | 1.03 |
| 2962 | Atrial fibrillation (PheCode 427.21) | GCST90475970 | 1.03 |
| 2963 | Diacylglycerol_34:1_[M+H-H2O]1+ levels | GCST90060179 | 1.03 |
| 2964 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T345 | ECGU000345 | 1.03 |
| 2965 | DTI TBSS L2 Superior longitudinal fasciculus L | GCST90384517 | 1.03 |
| 2966 | Right-hemisphere control network to accumbens white-matter structural connectivity | GCST90302842 | 1.03 |
| 2967 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T237 | ECGA000237 | 1.03 |
| 2968 | Right-hemisphere visual network to accumbens white-matter structural connectivity | GCST90302787 | 1.03 |
| 2969 | ENG/NCAM2 ratio | GCST90314647 | 1.03 |
| 2970 | Influenza and pneumonia | FING00000679 | 1.03 |
| 2971 | CASP3/SERPINE1 ratio | GCST90313643 | 1.03 |
| 2972 | Total cholesterol levels (UKB data field 23400) | GCST90269497 | 1.03 |
| 2973 | STXBP1 levels | GCST90470777 | 1.03 |
| 2974 | Atherosclerosis of native arteries of the extremities with intermittent claudication (PheCode 440.22) | GCST90475991 | 1.02 |
| 2975 | Left-hemisphere dorsal attention network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302696 | 1.02 |
| 2976 | CD40/GLOD4 ratio | GCST90313814 | 1.02 |
| 2977 | Type 1 diabetes with ketoacidosis (PheCode 250.11) | GCST90475662 | 1.02 |
| 2978 | Cardiovascular delta age (difference between cardiac MRI-predicted and chronological age) | GCST90239748 | 1.02 |
| 2979 | Hearing difficulty | GCST90044775 | 1.02 |
| 2980 | QC rfMRI cleaned inverse tSNR | GCST90006358 | 1.02 |
| 2981 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T325 | ECGU000325 | 1.02 |
| 2982 | Excessive, frequent and irregular menstruation | FING00000524 | 1.02 |
| 2983 | SLC4A1 levels | GCST90470663 | 1.02 |
| 2984 | ICD10 N97.8: Female infertility of other origin | GCST90454225 | 1.02 |
| 2985 | REN levels | GCST90470454 | 1.02 |
| 2986 | CCL22 levels | GCST90240490 | 1.01 |
| 2987 | mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed) | GCST90475456 | 1.01 |
| 2988 | Free cholesterol to total lipids in small HDL percentage (UKB data field 23647) | GCST90269744 | 1.01 |
| 2989 | ITGB1BP2/MITD1 ratio | GCST90315214 | 1.01 |
| 2990 | LAYN/ULBP2 ratio | GCST90315292 | 1.01 |
| 2991 | IDP dMRI ProbtrackX L2 unc l | GCST90004298 | 1.01 |
| 2992 | Methods of admission to hospital (recoded) - Elective admission: Booked | Summary Administration | UKBB00000461 | 1.01 |
| 2993 | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus R | GCST90004213 | 1.01 |
| 2994 | Synovitis and tenosynovitis (PheCode 727.1) | GCST90476242 | 1.01 |
| 2995 | Hypercholesterolemia | endocrine/metabolic | UKBB00000332 | 1.01 |
| 2996 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T483 | ECGA000483 | 1.01 |
| 2997 | Principal component-derived dietary pattern 23 | GCST90133028 | 1.01 |
| 2998 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T355 | ECGU000355 | 1.01 |
| 2999 | RARRES2 levels | GCST90470428 | 1.01 |
| 3000 | ADAMTS15/CLMP ratio | GCST90313170 | 1.00 |